OASIS Study: Vitamin D Deficiency Prevention Among Older Adults in Ireland
NCT ID: NCT06705582
Last Updated: 2025-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
117 participants
INTERVENTIONAL
2024-11-11
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The OASIS study will test the hypothesis that a vitamin D-fortified bread as part of a healthy diet that includes vitamin D-fortified foods is effective in preventing low vitamin D status during winter, and safe for older adults to consume.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietary Supplementation With 25-hydroxyvitamin D3 in Older Adults
NCT01398202
The BreaD Study - Bio-availability of D2 Vitamin Present in Bread
NCT02525003
Replenishing and Maintaining Vitamin D Status in Older Adults in Residential Care Facilities in NI
NCT04395638
An Intervention Study to Investigate the Effect of B-vitamin Supplementation for 2-years on Bone Health
NCT03892395
Vitamin D Status and Bone Health of Older Adults in Care Facilities
NCT04399291
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The target vitamin D intake for the treatment group in this study is \>15-20 μg/day vitamin D. This will maintain serum concentrations of 25-hydroxyvitamin D (25(OH)D) (the biomarker of vitamin D status) \> 30 nmol/L, the clinical deficiency threshold to prevent metabolic bone disease, in over 90% of participants. At this vitamin D intake level, about 80% of participants will have a 25(OH)D concentration \> 50 nmol/L, the personal intake target in the US and EU.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fortified bread
Intervention group will be supplied with fortified bread
Fortified Bread
Intervention group will be supplied with fortified bread delivering 10 -15 μg (400-600 IU) vitamin D3 in a daily portion and will receive dietary advice to incorporate fortified foods that are commonly available on the market in their diet.
Unfortified bread
Control arm will receive unfortified bread and dietary advice to incorporate fortified foods that are commonly available on the market in their diet.
Unfortified bread
Placebo control group will be supplied with unfortified bread and will receive dietary advice to incorporate fortified foods that are commonly available on the market in their diet.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fortified Bread
Intervention group will be supplied with fortified bread delivering 10 -15 μg (400-600 IU) vitamin D3 in a daily portion and will receive dietary advice to incorporate fortified foods that are commonly available on the market in their diet.
Unfortified bread
Placebo control group will be supplied with unfortified bread and will receive dietary advice to incorporate fortified foods that are commonly available on the market in their diet.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Be an adult ≥65 years.
3. Willing to consume bread provided and have storage capacity for frozen bread.
4. Be in good general health.
5. Be willing to follow the assigned diet for 10 weeks and attend the required appointments.
\-
Exclusion Criteria
2\. Exposure to factors that may influence vitamin D status, such as winter sun holiday, tanning bed usage.
3\. Are following a medically prescribed diet. 4. Have a diagnosis of an acute or chronic medical condition that in the opinion of the investigator would interfere with the outcomes of the study such as Coeliac disease, Inflammatory Bowel Disease, liver disease, renal disease, pancreatic disease or gastric disease.
5\. Have a history of active cancer or a diagnosis of cancer within the past 5 years.
6\. Are taking certain medications that can impact vitamin D status, such as glucocorticoids.
8\. Have regular excessive alcohol intake (≥28 units per week). 9. Have a known food allergy. 10. Are participating in another research study with an intervention or other lifestyle programme that would interfere with the outcomes of the study.
11\. Are unable to read, write, or understand English.
\-
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University College Dublin
OTHER
University College Cork
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mairead Kiely PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mairead E Kiely, PhD
Role: PRINCIPAL_INVESTIGATOR
University College Cork
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Human Nutrition Studies Unit, School of Food and Nutritional Sciences
Cork, Cork, Ireland
UCD Institute of Food and Health
Dublin, Dublin, Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OASIS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.